LCN2 and acute kidney injury: In conclusion, the urinary level of NGAL can serve as a sensitive and predictive biomarker for tacrolimus-induced AKI, and urinary NGAL-based monitoring of renal functions in liver transplant recipients may be a convenient and effective way of managing tacrolimus-induced AKI.